Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios

--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health--

ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today the closing of $8 million in financing. This funding will provide critical resources to accelerate commercialization efforts and strengthen the company’s ability to address significant unmet needs in women’s reproductive health. To underscore this momentum, Femasys’ largest shareholder, Jorey Chernett also provided commentary on the company’s mission and recent milestones.

Read more at globenewswire.com